PRRT2 and Hyperglycemia: The PKC pathway becomes activated through hyperglycemia-induced increases in diacylglycerol (DAG), with PKC-β and PKC-δ isoforms particularly implicated in stimulating NOX activity while inhibiting AMPK-mediated antioxidant responses (Geraldes and King, 2018).